Cerebral set to pay $7M over alleged patient data sharing
By 
Jeff Dale2024-06-12T02:05:00
The Department of Justice (DOJ) and Federal Trade Commission proposed telehealth company Cerebral pay a total of $7 million for its alleged sharing of patient data and deceptive business practices in violation of the FTC Act.
Cerebral was ordered to pay $5 million in consumer redress and a $10 million civil penalty, which was suspended to $2 million based on the company’s limited ability to pay, the DOJ announced in a press release Monday.
The order, pending approval by the U.S. District Court for the Southern District of Florida, requires the company to cease misusing and improperly disclosing patient information, misrepresenting its data privacy or security practices, and misrepresenting its cancellation practices.
Related articles
-
News BriefMobile health apps must follow FTC breach notice rule after update
Mobile health applications and similar technologies must notify customers following a data breach or risk violating the Federal Trade Commission’s health breach notification rule.
-
News BriefFTC, HHS warn hospitals over use of online tracking tech
The Federal Trade Commission and Department of Health and Human Services sent letters to approximately 130 hospital systems and telehealth providers regarding potential patient privacy violations and security risks stemming from online tracking technologies.
-
News BriefSens press telehealth firms on alleged sharing of patient data for ads
A bipartisan group of senators is leaning on three telehealth firms accused of tracking and sharing patients’ sensitive personal information with advertising platforms like Google and Facebook.
More from Regulatory Enforcement
-
News BriefCFPB ends probe into Meta’s financial advertising practices
Meta says it is no longer under investigation by the U.S. Consumer Financial Protection Bureau (CFPB), the latest instance of the agency scaling back enforcement under President Donald Trump.
-
News BriefTexas sues Johnson & Johnson, Kenvue over alleged misleading marketing of Tylenol
Texas Attorney General Ken Paxton sued two pharmaceutical companies for ”deceptively marketing Tylenol to pregnant mothers” despite risks linked to autism. The filing came two days before HHS Secretary Robert F. Kennedy Jr. appeared to walk back the claims.
-
News BriefCFPB scraps bad-actor registry, citing cost-benefit issues
The Consumer Financial Protection Bureau shut down a registry of non-bank financial firms that broke consumer laws. The agency cites the costs being ”not justified by the speculative and unquantified benefits to consumers.”